Moving from ‘Luck of the Draw’ to making BLS and Defibrillator availability basic

The AHA ReSS council had a fascinating 2021 meeting, including trials making us reassess the optimal temperature for patients following cardiac arrest (TTM2) and those investigating the potential new application of existing meds repurposed to cardiac arrest (e.g. Tocilizumab [IL-6 inhibitor] to reduce cytokine storm post-arrest, LPC-DHA to improve mitochondrial function). What really put these … Read more

Mental Health at the Forefront of Cardiovascular Health Discussions at AHA21

Mental health was a big topic of conversation at AHA21, a fitting topic when pandemic related stress, clinician burn out, and depression seem to be at an all-time high. As a graduate student myself, I was interested in attending sessions that touched on depression, wellness, and work-life balance topics. A Health and Tech panel session … Read more

Cut from the same clot? – High-risk primary prevention vs secondary prevention in CVD

Atherosclerotic cardiovascular disease (CVD) prevention has been traditionally divided into primary or pre-event prevention and secondary or re-event prevention. The AHA 2021 joint session with the American Society of Preventive Cardiology entitled “Blurred Lines-Overlap in High-Risk Primary Prevention vs Secondary Prevention” challenged this traditional concept. The session tackled the case of a high-risk patient where … Read more

Fruits, Vegetables, Wholegrains, Plant proteins, and your Heart

Cardiovascular diseases (CVD) are the leading cause of death in Western countries and accounts for 17.3 million deaths/year globally1. In the United States, one in every three deaths are caused by CVD, and more than 130 million adults are projected to express CVD by 2035 clinically1. The unhealthy diet and physical inactivity, obesity, stress, smoking, … Read more

2021 Chest Pain Guidelines from AHA21

2021 Guideline for the Evaluation and Diagnosis of Chest Pain was released in October 2021 and discussed in multiple sessions during AHA21. It was a collaboration between cardiologists, interventional cardiologists, cardiac intensivists, epidemiologists, and emergency medicine specialists. The team has focused on a symptom rather than a disease, making this approach unique. In the U.S, … Read more

On Demand: Health Equity at #AHA21

As you may know, health equity was a major focus of the AHA 2021 Scientific Sessions, with numerous sessions that focused on cardiovascular health disparities, equity in treatment of cardiovascular disease and plenty of original health equity research. Here is a run-down of some great presentations about important topics in cardiovascular health equity from #AHA21, … Read more

Equity, Diversity, and Inclusion: The Pillars of #AHA21

I was delighted to be selected as one of the American Heart Association (AHA) early career fellows in training bloggers for the year 2021-2022 during my first-year cardiology fellow. During 2019, the AHA conference was in Philadelphia and in-person. However, with the COVID-19 pandemic surge, we have learned how to attend virtual to hybrid conferences. … Read more